4.5 Article

Loss of the scavenger mRNA decapping enzyme DCPS causes syndromic intellectual disability with neuromuscular defects

Journal

HUMAN MOLECULAR GENETICS
Volume 24, Issue 11, Pages 3163-3171

Publisher

OXFORD UNIV PRESS
DOI: 10.1093/hmg/ddv067

Keywords

-

Funding

  1. Ligue Contre le Cancer
  2. Centre National pour la Recherche Scientifique
  3. CERBM-IGBMC
  4. Agence Nationale pour la Recherche [ANR-11-BSV8-009-02, ANR-10-LABX-0030-INRT, ANR-10-IDEX-0002-02]
  5. NIH/National Institute of Arthritis Musculoskeletal and Skin (NIAMS) through the Center for Duchenne Muscular Dystrophy [NIH-P30-5P30AR057230]
  6. Society in Science Branco Weiss Foundation
  7. A*STAR, Singapore [SPF2012/005]

Ask authors/readers for more resources

mRNA decay is an essential and active process that allows cells to continuously adapt gene expression to internal and environmental cues. There are two mRNA degradation pathways: 3' to 5' and 5' to 3'. The DCPS protein is the scavenger mRNA decapping enzyme which functions in the last step of the 3' end mRNA decay pathway. We have identified a DCPS pathogenic mutation in a large family with three affected individuals presenting with a novel recessive syndrome consisting of craniofacial anomalies, intellectual disability and neuromuscular defects. Using patient's primary cells, we show that this homozygous splice mutation results in a DCPS loss-of-function allele. Diagnostic biochemical analyses using various m(7)G cap derivatives as substrates reveal no DCPS enzymatic activity in patient's cells. Our results implicate DCPS and more generally RNA catabolism, as a critical cellular process for neurological development, normal cognition and organismal homeostasis in humans.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.5
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available